There were 1,127 press releases posted in the last 24 hours and 221,925 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Biodol Therapeutics receives EUR 4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures

TO:
Ward Capoen
V-Bio Ventures
+32 476 33 68 77

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image